Canopy Launches First Intelligent Care Platform for Oncology

Canopy, the Intelligent Care Platform (ICP) for oncology, recently announced it has raised $13 million in funding led by GSR Ventures, with participation from Samsung Next, UpWest, and other industry leaders and executives, such as Geoff Calkins (former SVP Product, Flatiron Health), and Chris Mansi (CEO Of Viz.AI).

Today’s cancer patient journey means a significant risk of infection on every trip to the hospital. Long waiting times for necessary test results put cancer patients in a position of increased infection in the hospital environment.

Canopy’s platform designed to allow practices to improve patient outcomes at lower cost, Canopy’s platform includes a full suite of intelligent EMR-integrated solutions, such as Remote Patient Monitoring, Chronic and Principal Care Management tools, Oral Oncolytics solutions, Provider workflow tools, as well as automated reimbursement capture.

Canopy has numerous leading cancer treatment centers across the U.S. live on the platform and is growing 160 percent per year, with 90 percent and 68 percent of patients still engaged after six and 18 months respectively.

Canopy plans to make its platform generally available to cancer treatment centers across the U.S. Canopy’s model enables physicians to interact with their patients continuously and proactively.

Working with leading oncology practices nationwide, Canopy’s platform has demonstrated high rates of patient enrollment (86 percent), engagement (88 percent), retention (90 percent at 6 months), and timely nursing intervention rates (88 percent).

Canopy is the preferred vendor for the Quality Cancer Care Alliance (QCCA) and works with leading oncology practices across the country.


Takeaway: As home-based oncology programs develop, the role of the hospital in the treatment of patients with cancer will evolve. Home-based care will transition to serve as a more central care setting for a significant percentage of cancer patients